These results indicated that the increased degree of m6A modification enhanced the stability of PHKA1‐AS1 in NSCLC cells and led to increased expression of PHAK1‐AS1, thus promoting the progression and metastasis of NSCLC. The gene discussed is PHKA1; the disease is non-small cell lung carcinoma.